Gene Query: MRPL40

Dataset Description Geneva Score
3’READS+, a sensitive and accurate method for 3’ end sequencing of polyadenylated RNA 32.93
Distinct regulation of alternative polyadenylation and gene expression by nuclear poly(A) polymerases 19.17
Response of HEK293 Freestyle cells to 36 h of culture in Zn(II)-depleted Freestyle medium 19.15
SRSF2 mutations impair hematopoiesis and alter exon recognition 17.86
Global analysis of enhancer targets: Mosaic-seq 15.08
Post-transcriptional manipulation of TERC reverses molecular hallmarks of telomere disease 14.59
SLAM-seq for K562 endogenous mRNA decay 14.34
Transcriptome analysis of human immortilized astrocytes reprogrammed into dopaminergic neurons 14.19
Combined inhibition of STAT3 and DNA repair in palbociclib-resistant ER-positive breast cancer 14.02
CDK4/6 inhibitor resistance in prostate cancer 12.96
Quantitative analysis of bi-modal binding of BET proteins at promoters predicts I-BET sensitivity 12.77
An atlas of TNF-α-responsive promoters and enhancers in the intestinal epithelial cell model Caco-2 12.59
Cell-to-cell variation in defective virus expression and effect on host response during influenza virus infection 12.44
Sequencing Universal Human Reference RNA by Smart-seq and early barcoding library preparation methods 12.13
Complete deconvolution of cellular mixtures based on linearity of transcriptional signatures 11.93
The comparison of high-throughput single-cell RNA-seq methods 11.53
Proteinase-Activated Receptor 4 (PAR4) mediates cell membrane blebbing in a Gaq/11, Gai independent, RhoA and ß-arrestin-dependent manner. 11.47
K562 polyA RNA-Seq 11.09
The X-linked DDX3X RNA helicase dictates translation re-programming and metastasis in melanoma 11.02
Precise Gene Editing Preserves Hematopoietic Stem Cell Function Following Transient p53-Mediate DNA Damage Response 10.15
Transcription elongation factors are in vivo-specific cancer dependencies in glioma 9.9
RNA-seq Profiles in Transcription elongation factors are in vivo-specific cancer dependencies in glioma 9.9
Spliceosomal disruption of the non-canonical BAF complex in cancer 9.64
RNA-seq and m6A-seq of AML cells with FTO knockdown or inhibition 9.62
DART-seq: an antibody-free method for global m6A detection 9.2
CXCR4 is a host factor that regulates Plasmodium development in hepatocytes 9.16
N6-methyladenine DNA Modification in Glioblastoma 9.13
N6-methyladenine DNA Modification in Glioblastoma [RNA-seq] 9.13
Kidney organoid reproducibility across multiple human iPSC lines and diminished off target cells after transplantation revealed by single cell transcriptomics 8.9
The effect of PPARG inhibition on human angiomyolipoma cells 8.88
Generating Patterned Kidney Organoids for Studying Development and Diseases 8.84
Human Treg IL-12 stimulation 8.7
Effects of NSUN2 deficiency on the mRNA 5-methylcytosine modification and gene expression profile in HEK293 cells (RNA-Seq) 8.68
Reprogramming of Tumor-infiltrating Immune Cells in Early Stage of NSCLC 8.63
Single-cell RNA sequencing-based CRISPRi screening resolves molecular drivers of early human endoderm development [set 1] 8.53
CRISPR adenine and cytosine base editors with reduced RNA off-target activities 8.44
CRISPR adenine and cytosine base editors with reduced RNA off-target activities [CBE] 8.44
RNA-seq of PC3 prostate cancer cell line xenografts in mice administered the ghrelin receptor antagonist [D-Lys3]-GHRP-6 or PBS for two weeks 8.36
A Hybrid Mechanism of Action for BCL6 in B Cells Defined by Formation of Functionally Distinct Complexes at Enhancers and Promoters 8.34
Tracking of dCas9-methyltransferase footprints 7.98
ETV7 and interferon response 7.83
Impact of ETV7 activity on interferon-stimulated gene expression in 293T cells treated with interferon alpha 7.83
Dynamic and stable enhancer-promoter contacts regulate terminal differentiation [RNA-Seq] 7.75
Dynamic and stable enhancer-promoter contacts regulate terminal differentiation 7.75
Disease modelling of core pre-mRNA splicing factor haploinsufficiency 7.53
A Surveillance System of Active Enhancers by a RACK7-histone Demethylase Complex 7.44
Exercise-induced transcriptome changes in skeletal muscle adapted to aerobic training 7.26
UMI-count modeling and differential expression analysis for single-cell RNA sequencing 7.22
Systematic discovery of endogenous human ribonucleoprotein complexes 7.12
p38 SAPK and SKIIP induced changes in alternative splicing patterns upon osmostress 7.08
Medial Ganglionic Eminence and Cortical Organoids Model Human Brain Development and Interneuron Migration 7.04
Glutaminolysis is a metabolic dependency in FLT3 ITD Acute Myeloid Leukemia unmasked by FLT3 Tyrosine Kinase Inhibition 7.02
RNAseq of HEK293 cells after Chtop knockdown 6.9
Co-transcriptional loading of RNA export factors shapes the human transcriptome 6.9
MOF acetyl transferase regulates transcription and respiration in mitochondria 6.89
Nickel induced transcriptional changes persist post exposure through epigenetic reprograming (ChIP-seq & RNA-seq datasets) 6.75
Transcriptomes analysis for the regulation of Z36 induced autophagy in HeLa cell death 6.7
DNMT and HDAC inhibitors globally induce cryptic TSSs encoded in long terminal repeats 6.67
Whole Transcriptome RNASeq Data for Cell-Sorted Antibody Secreting Cells (ASC) 6.5
Transcriptional profiling of microglia; current state of the art and future perspectives 6.46
Ets homologous factor has critical roles in epithelial dysfunction in airway disease 6.35
Ets homologous factor has critical roles in epithelial dysfunction in airway disease [RNA-seq] 6.35
The RNA hairpin binder TRIM71 modulates alternative splicing by repressing Mbnl1 [RNA-seq & Ribo-seq] 6.34
The RNA hairpin binder TRIM71 modulates alternative splicing by repressing MBNL1 6.34
CROP-Seq in Primary Human T Cells 6.33
Adaptive chromatin remodeling in glioblastoma stem cell plasticity and drug tolerance 6.22
Control of prostate tumour growth by the long non-coding RNA GHSROS (LNCaP) 6.17
Endogenous retroviruses are a source of oncogenic enhancers in acute myeloid leukemia 6.11
Endogenous retroviruses are a source of oncogenic enhancers in acute myeloid leukemia [RNA-Seq] 6.11
A quantitative chemotherapy genetic interaction map identifies new factors associated with PARP inhibitor resistance 6.11
Next Generation Sequencing of control (Untreated), PAN injured and Adriamycin injured human podocytes 6.03
RNA-seq, ChIP-seq and single cell RNA-seq of human skin Langerhans cells 5.84
Ex-vivo Human Hematopoietic Stem Cell Expansion Requires Coordination of Cellular Reprogramming with Mitochondrial Remodeling and P53 Activation 5.83
Control of prostate tumour growth by the long non-coding RNA GHSROS 5.74
Activating PAX Gene Family Paralogs to Complement PAX5 Leukemia Driver Mutations 5.66
Next Generation RNA Sequencing Analysis of AMPK Wild Type, AMPKα-KO and AMPKα1-2A U2OS cell Transcriptomes 5.55
Expression analysis of genes modulated after knock-down of lncRNA CHROME. 5.55
Food-derived Compounds Apigenin and Luteolin Modulate mRNA Splicing of Introns with Weak Splice Sites 5.48
Multiplexed engineering and analysis of endogenous enhancer activity in single cells: Mosaic-Seq of beta-globin locus (pooled infection) 5.44
Next Generation Sequencing Facilitates Quantitative Analysis of SW480 cells and HPSE-knockdown SW480 cells Transcriptomes 5.43
Disrupted prenatal RNA processing and myogenesis in congenital myotonic dystrophy 5.42
transcriptomic profiling of HEK293 cells upon individual knockdown of the splicing factors RBM17, U2SURP or CHERP 5.4
Grainyhead-like 2 is essential for androgen receptor expression and activity in prostate cancer (RNA-seq) 5.38
Grainyhead-like 2 is essential for androgen receptor expression and activity in prostate cancer 5.38
TimeLapse-seq: adding a temporal dimension to RNA sequencing through nucleoside recoding 5.18
The SPOP-containing Complex Functions as an E3 Ligase for SETD2 to Regulate Gene-Specific H3K36me3-Coupled Alternative Splicing 5.13
ARS2 is a general suppressor of pervasive transcription [RNAseq] 5.13
Lysine benzoylation is a novel histone mark [RNA-seq] 5.12
Lysine benzoylation is a novel histone mark 5.12
Innate-like activation of mucosal-associated invariant T cells in mycobacterial infection 5.01
Sirt6 Oncogene Mediates PI3K/Akt Signaling Activation in Diffuse Large B-Cell Lymphoma 4.98
Global analysis of pre-mRNA subcellular localization upon splicing inhibition by spliceostatin A 4.94
Human co-transcriptional splicing kinetics and coordination revealed by direct nascent RNA sequencing 4.88
Expanding the Nucleoside Recoding Toolkit: Revealing RNA Population Dynamics with 6-thioguanisine 4.87
DHX36 is the missing link to understand RNA G-quadruplex structures, mRNA stability, and translation [RNA-seq] 4.85
Effect of CHKA knockdown on C4-2 cell transcriptome 4.85
Expression profile of HNF1A knockdown and overexpression in 22RV1 and LNCaP cells respectively 4.82
TRIM28 interacts with EZH2 and SWI/SNF to activate genes that promote mammosphere formation 4.81
Biochemical fractionation of HEK293 nuclei and RNA-seq of chromatin-associated and soluble-nuclear RNA 4.64
Binding to SMN2 pre-mRNA-Protein complex elicits specificity for small molecule splicing modifiers 4.63
RNA-seq and ChIP-seq analysis of BMI1 or RING1B-silenced prostate cancer cells C4-2 4.61
An integrative analysis of non-coding regulatory DNA variations associated with autism 4.61
Expression changes in melanoma cell lines under BRAFi treatment timepoints [RNA-Seq.CellLine.batch4] 4.59
Gene expression profiling of papillary thyroid cancer from central and invasive regions 4.57
Splicing towards noncoding isoforms in colorectal carcinoma is associated with tumor hypoxia and the DNA damage response 4.56
A pooled single-cell genetic screen identifies regulatory barriers in the continuum of the epithelial-to-mesenchymal transition 4.56
pSILAC mass spectrometry reveals ZFP91 as novel IMiD dependent substrate of the CRL4CRBN ligase 4.54
Expression profiling by high throughput sequencing of tumors derived from human prostate epithelial cells transformed with the oncogenes N-Myc and myrAKT1. 4.53
Comprehensive molecular phenotypic effects of the large deletion on chromosome 22q11.2 4.49
Maintaining iron homeostasis is the key role of lysosomal acidity for cell proliferation 4.47
Long non-coding RNA TYKRIL controls pericyte function and survival in the cardiovascular and central nervous system through regulation of p53 activity and PDGFRß expression 4.45
Low carbohydrate diet study for non-alcoholic fatty liver disease patients 4.45
Epigenetic reprogramming at estrogen-receptor binding sites alters the 3D chromatin landscape in endocrine resistant breast cancer [RNA-seq] 4.42
Epigenetic reprogramming at estrogen-receptor binding sites alters 3D chromatin landscape in endocrine resistant breast cancer 4.42
In vitro differentiation of human embryonic stem cells into ovarian follicle-like cells 4.4
Species-specific maturation profiles of human, chimpanzee and bonobo neural cells 4.39
scRNASeq analysis of cycling cardiomyocytes 4.38
The multiple myeloma risk allele at 5q15 lowers ELL2 expression and increases ribosomal gene expression [ELL2 KO] 4.38
Definition of Natural Killer cell heterogeneity in humans and mice by high-throughput single-cell RNA sequencing 4.37
Single-cell RNA sequencing-based CRISPRi screening resolves molecular drivers of early human endoderm development 4.35
Thymine DNA Glycosylase as a novel target for melanoma: effect of TDG silencing on gene expression in SK-mel-28 melanoma cells 4.35
Mutually Exclusive CBC-Containing Complexes Contribute to RNA Fate. 4.2
H3K27ac ChIP-Seq and mRNA-Seq analysis of five human B-lymphoblastoid cell lines (LCLs) prepared from the same healthy male individual (CEPH/UTAH). 4.19
RNA sequencing of MDA-MB231 and U2OS cancer cell lines exposed to the alkylating agent methyl methanesufonate (MMS) and classical chemotherapeutics  4.18
RNA seq comparison between scrambled and shGRP78 cells 4.18
Functional Importance of eRNAs for Estrogen-dependent Gene Transcriptional Activation 4.17
A systematic analysis of nuclear heat-shock protein 90 identifies a metazoan-specific regulatory module 4.17
Macrophage Ad5f35 M2 Challenge 4.16
The long non-coding RNA MALAT1 contributes to the pathogenesis of multiple sclerosis through alternative splicing and backsplicing regulation 4.14
Genome-wide discovery of human splicing branchpoints [RNAse] 4.13
Acriflavine inhibits the epithelial-to-mesenchymal transition in vitro in liver and pancreatic cancer cells (part of study on HepG2) 4.12
A novel lncRNA GAS1 promotes gastric carcinogenesis and acts as a modular scaffold of WDR5 and KAT2A complexes to specify the histone modification pattern [RNA-seq] 4.12
ChIP-seq and RNA-seq in BGC823 cells after downregulation of GAS1 expression 4.12
U1 snRNP telescripting regulates size-function stratified human genome 4.11
12hr 5-FU treatment vs. DMSO in SJSA cells (from 'A kinase independent role for CDK19 in p53 response') 4.1
Identification of diverse target RNAs that are functionally regulated by human Pumilio proteins 4.07
Single-nucleotide-resolution mapping of HBV promoters using CAGE 4.06
Transcriptional responses of melanoma cells to BRAF inhibition 4.05
Gene target specificity of the Super Elongation Complex (SEC) family: How HIV-1 Tat employs selected SEC members to activate viral transcription 4.05
Genome-wide probing of RNA structure reveals active unfolding of mRNA structures in vivo 3.97
The evolution of N6-methyladenosine in primates 3.95
Loss of histone macroH2A1 in hepatocellular carcinoma cells promotes paracrine-mediated chemoresistance and CD4+CD25+ T regulatory cells activation 3.95
Transcriptional impact of MTHFD2 in Human Aortic Endothelial Cells 3.93
RBM25 is a global splicing factor promoting inclusion of alternatively spliced exons 3.92
The E3 ubiquitin ligase HectD1 suppresses EMT and metastasis by targeting the +TIP protein ACF7 for degradation 3.91
Gene expression profile in response to HIF-1α inhibition together with PPARα activation and the postnatal factors (T3, IGF-1 and dexamethasone) in hiPSC-CMs 3.91
Activation of a SOX2-dependent transcriptional regulatory circuit drives glioblastoma. 3.9
Identification of a core p53 transcriptional program with highly fractionated tumor suppressive activity 3.87
GRO-seq from HCT116, MCF7 and SJSA cell lines treated with DMSO and Nutlin 3.87
Effect of Ro 08-2750 treatment on gene expression of human leukemia cell lines MOLM13 and K562 3.85
Deciphering the ‘m6A code’ via quantitative profiling of m6A at single-nucleotide resolution [III] 3.84
Deciphering the ‘m6A code’ via quantitative profiling of m6A at single-nucleotide resolution 3.84
Genes directly regulated by NF-κB in human hepatocellular carcinoma HepG2 3.84
Genes directly regulated by NF-κB in human hepatocellular carcinoma HepG2 [RNA-seq] 3.84
The stress granule transcriptome reveals principles of mRNA accumulation in stress granules. 3.83
Selective expansion of myeloid and NK cells in humanized mice yields human-like vaccine responses (Experiment 1: RNA-seq) 3.83
Cap-specific terminal N6-methylation of RNA by an RNA polymerase II-associated methyltransferase. 3.83
Trans-differentiation of human adult peripheral blood T cells into neurons 3.8
Ewing sarcoma resistance to SP-2509 is not mediated through KDM1A/LSD1 mutation I 3.8
A single-cell atlas of the human cortex reveals drivers of transcriptional changes in Alzheimer’s disease in specific cell subpopulations 3.79
RNAseq analysis of patient-derived luminal breast cancer xenografts treated with progestins 3.78
Patient-derived luminal breast cancer xenografts with progestins 3.78
Pseudotime Ordering of Single Human Beta-Cells Reveals States of Insulin Production and Unfolded Protein Response 3.75
MicroRNA (miR)-211 loss promotes metabolic vulnerability and BRAF inhibitor sensitivity in melanoma 3.72
RNA-Seq with and without RNase treatment in PCa cell lines 3.71
Transcriptome sequencing of K-562 cells 3.71
Knockdown of ADNP in HCT116 colon cancer cells 3.69
Exogenous pyruvate represses histone gene expression to inhibit cancer cell proliferation via the NAMPT-NAD + -SIRT1 pathway 3.66
RNA-sequencing of shSRC-1 and shNT tamoxifen treated LY2 cells 3.64
RNA-sequencing and MeDIP-sequencing of shSRC-1 and shNT tamoxifen treated LY2 cells 3.64
mRNA destabilization is the dominant effect of mammalian microRNAs by the time substantial repression ensues 3.62
mRNA destabilization is the dominant effect of mammalian microRNAs by the time substantial repression ensues (sequencing) 3.62
Mapping interactions for the TNIP2 hub protein 3.61
Cohesin and CTCF Differentially Affect the Chromatin Architecture and Gene Expression in Human Cells 3.61
RNA sequencing based comparative analysis of human hepatic progenitor cells and their niche from alcoholic steatohepatitis livers 3.6
WNK1 kinase and the termination factor PCF11 connect nuclear mRNA export with transcription 3.59
A novel compound that blocks HIV-1 replication inhibits the splicing regulatory function of SRSF10 3.58
24hr CA treatment vs. DMSO in HCT116 cells (from 'Identification of CDK8 and CDK19 substrates in human cells using cortistatin A and quantitative phosphoproteomics') 3.57
RNAseq of Extracellular vesicle RNAs and cellular RNAs from HPASMCs with or without TGF-b1 or BMP4 treatment 3.53
Coordinate regulation of alternative pre-mRNA splicing events by the human RNA chaperone proteins hnRNPA1 and DDX5 3.53
Interaction with WDR5 recruits MYC to a small cohort of genes required for tumor onset and maintenance 3.53
Genome-wide maps in MCF-7 cells with six2 or CYP4Z1 3'UTR or CYP4Z2P 3'UTR overexpression or not 3.51
Dynamics of the human and viral m6A RNA methylomes during HIV-1 infection of T cells 3.49
Quantitative Analysis of PPARD Transcriptomes in Colon Cancer Cells by Next Generation Sequencing (NGS) 3.49
The regulartory role of ZCCHC24 in splicing machinery 3.48
Detection of internal N7-methylguanosine (m7G) RNA modifications by mutational profiling sequencing 3.47
Functional role of SLIT2 and ROBO1 in trophoblasts 3.46
RNA editing in nascent RNA affects pre-mRNA splicing 3.45
Transcriptomics analysis of gene expression in multiple human and mouse cells and tissues 3.43
METTL3 promotes translation in human cancer cells 3.37
Tumors with TSC mutations are sensitive to CDK7 inhibition through NRF2 and glutathione depletion 3.34
mRNA-seq from Nutlin-3a, doxorubicin, and DMSO treated HCT116 p21-/- cells 3.34
Sequencing-based analyses characterize a tumor suppressive role of mir-1271 repressed by DNA hypermethylation in gastric cancer 3.33
Characterization of parental and rociletinib-resistant derived H1975 cell lines 3.32
Quantitative mass spectrometry-based proteomics reveals the dynamic protein landscape during initiation of human Th17 cell polarization 3.32
CD95L derived si- and shRNAs kill cancer cells through an RNAi mechanism by targeting survival genes [shL3.shR6.RNAseq.lg] 3.3
Pervasive transcription read-through promotes aberrant expression of oncogenes and RNA chimeras in renal carcinoma 3.26
Sensitivity and engineered resistance of myeloid leukemia cells to BRD9 inhibition (RNA-seq) 3.26
Sensitivity and engineered resistance of myeloid leukemia cells to BRD9 inhibition 3.26
miRNAs affected by antagomiR-17 treatment 3.25
Mucosal Profiling of Pediatric-Onset Colitis and IBD Reveals Common Pathogenics and Therapeutic Pathways 3.23
Transcriptome profiling of Caki2 cells re-expressing Polybromo-1 (PBRM1) 3.22
Incomplete MyoD-induced transdifferentiation is mediated by chromatin remodeling deficiencies 3.21
Incomplete MyoD-induced transdifferentiation is mediated by chromatin remodeling deficiencies [RNA-Seq] 3.21
β-catenin/Tcf7l2 dependent transcriptional regulation of GLUT1 gene expression by Zic family proteins in colon cancer 3.18
Alu RNA modulates the expression of cell cycle genes in human fibroblasts 3.18
Next Generation Sequencing of Transcriptomes of Cutaneous Melanocytes and Metastatic Melanoma Cell Lines 3.15
Next Generation Sequencing of Transcriptomes of Cutaneous Melanocytes and Metastatic Melanoma Cell Lines (mRNA-Seq) 3.15
Cis-SAGe fusion RNAs in transcription splicing factors knocking-down 293T cells 3.14
ARID1A and PI3-Kinase pathway mutations in the endometrium drive epithelial transdifferentiation and collective invasion [12Z_RNA-seq] 3.13
Expression charcaterization of an internal protocol developed to differentiate RPE cells 3.12
Landscape and variation of RNA secondary structure across the human transcriptome 3.11
Single-cell Map of Diverse Immune Phenotypes in the Breast Tumor Microenvironment - 5' RNA sequencing and TCR sequencing 3.11
Transcriptome-wide identification of splicing defects upon XAB2 knockdown 3.1
UPA-Seq: Prediction of functional lncRNAs using the sensitivities to UV-crosslinking 3.1
A transcriptome-wide divergence in protein translation scales with LIN28B expression 3.08
Profiling of protrusion-enriched RNAs from human breast cancer cell line MDA-MB-231 3.08
Accurate annotation of human protein-coding small open reading frames 3.08
Human embryonic stem cell, chimpanzee induced pluripotent stem cell, orangutan induced pluripotent stem cell, rhesus embryonic stem cell, and their derived cortical organoid RNA-seq 3.07
MPTAC determines APP fragmentation via sensing sulfur amino acid catabolism 3.07
Targeting Glioblastoma Stem Cells through Disruption of the Circadian Clock [RNA-Seq] 3.07
Targeting Glioblastoma Stem Cells through Disruption of the Circadian Clock 3.07
Triple vectors expand AAV transfer capacity in the retina 3.06
Poly(ADP-ribosyl)ation dependent changes in CTCF-chromatin binding and gene expression in breast cells 3.04
CXCR4 regulates extra-medullary myeloma through epithelial-mesenchymal transition-like transcriptional activation 3.02
The pause-initiation limit restricts transcription activation in human cells 3.01
Transcriptome profiles of moderate dysplasia in oral mucosa associated with malignant conversion 3.01
Inhibition of the Aryl Hydrocarbon Receptor - Polyamine Biosynthesis Axis Suppresses Multiple Myeloma and prostate cancer progression 2.99
Targeted transcriptional modulation with type I CRISPR-Cas systems in human cells 2.97
Targeted transcriptional modulation with type I CRISPR-Cas systems in human cells (RNA-seq) 2.97
Expression data for KDM1B knockdown in Glioma-Initiating Cells (GICs) 2.95
Identification of transcription start sites for human A549 cell line using ReCappable-seq 2.94
Single-cell RNA Sequencing Resolves Spatiotemporal Development of Pre-thymic Lymphoid Progenitors and Thymus Organogenesis in Human Embryos 2.94
SETBP1-WT and SETBP1-G870S epigenetic landscapes 2.92
SETBP1-WT and SETBP1-G870S transcriptional profiles [RNA-Seq] 2.92
Gene expression signatures of innate lymphoid cells from human blood 2.86
RNA-sequencing (RNA-seq) in BxPC-3 and S2-007 cell lines 2.86
Expression data from A2780 cells treated with DMSO, Olaparib(Ola), Palbociclib(PD), and their combination (Ola/PD) 2.85
Genome-wide detection of DNase I hypersensitive sites in single cells and FFPE tissue samples 2.85
Study functions of ADAR proteins using next generation sequencing of genome and transcriptome 2.84
ATRX is necessary for cellular senescence and represses HRAS to drive cells from quiescence into senescence 2.84
ATRX is necessary for cellular senescence and represses HRAS to drive cells from quiescence into senescence [RNA-Seq] 2.84
Immune-restricted epigenetic reader SP140 maintains macrophage identity and activation states critical to intestinal homeostasis 2.84
Immune-restricted epigenetic reader SP140 maintains macrophage identity and activation states critical to intestinal homeostasis [RNA-seq] 2.84
Identification of a LIF-responsive replication-competent human β cell 2.83
ZMYND8 reads the dual histone mark H3K4me1-H3K14ac to antagonize the expression of metastasis-linked genes 2.82
Single-cell Transcriptomic Atlas of the Human Retina Identifies Cell Types Associated with Age-Related Macular Degeneration 2.82
TrapSeq: An RNA Sequencing-based pipeline for the identification of genetrap insertions in mammalian cells 2.82
Effect of ER stress on MUC1 kidney disease patient derived cells and and treatment by BRD4780 2.81
Gene expression profiling by RNA-seq in hTert-HME1 cell line treated with control or BRCA2 siRNAs and grown with or without EGF (epithelial growth factor) 2.8
Single-cell transcriptomic analysis of tissue resident memory T cells in human lung cancer [ 10x genomics] 2.8
Effect of PRDM11 depletion in U2932 cells 2.78
Comprehensive comparative analysis of RNA sequencing methods for degraded or low input samples 2.77
Identification of mRNAs with reduced ribosomal loading upon knock-down of translation factor DAP5 from hESCs. 2.74
RNA-sequencing of tamoxifen-resistant and -sensitive breast cancer cell lines. 2.73
Genomic basis for clinical response to histone deacetylase inhibition in advanced urothelial carcinoma 2.71
Energy Metabolism during Anchorage-Independence 2.71
Next Generation Sequencing Facilitates Quantitative Analysis of miR-29b-1 and miR-29a targets in tamoxifen-sensitive and tamoxifen-resistant human breast cancer cells 2.71
Nascent RNA Sequencing after NMYC activation in SH-EP MYCNER cells 2.67
Single-cell Transcriptomics reveals multi-step adaptations to endocrine therapy 2.66
Solid phase chemistry to covalently and reversibly capture thiolated RNA 2.65
HNF1A deficiency impairs β-cell fate, granule maturation and function 2.64
The NORAD lncRNA assembles a topoisomerase complex critical for genome stability [RNA-seq] 2.64
The NORAD lncRNA assembles a topoisomerase complex critical for genome stability 2.64
ZNF599 and DNMT3A coordinately control nuclear envelope organization by repression of SUN4 expression 2.64
Controlling for gene expression changes in transcription factor protein networks. 2.63
Integrative classification of human coding and non-coding genes based on RNA metabolism profiles 2.63
IGF2BP1 promotes SRF-dependent transcription in cancer in a m6A- and miRNA-dependent manner 2.63
IGF2BP1 promotes SRF-dependent transcription in cancer in a m6A- and miRNA-dependent manner [Huh-7] 2.63
Abnormal RNA splicing and genomic instability after induction of DNMT3A mutations by CRISPR/Cas9 gene editing [RNA-Seq] 2.61
Abnormal RNA splicing and genomic instability after induction of DNMT3A mutations by CRISPR/Cas9 gene editing 2.61
The hepatitis C viral protein NS5A stabilizes growth-regulatory human transcripts 2.59
Single-cell RNAseq analysis of the empty and i8TF cell lines after 3 days of BL-CFC culture 2.59
Single cell transcriptomics reveals new insights on the dynamical function of transcription factors during blood stem and progenitor cell formation 2.59
MYC interacts with the G9a histone methyltransferase to drive transcriptional repression and tumorigenesis 2.57
FBXW7 modulates stress response by post-translational modification of HSF1 2.55
Transriptional profiling upon heat shock and recovery in cells deficient for FBXW7 and their wild type counterpart. 2.55
Effect of estrogen (E2) treatment on the C4-12 relative to the MCF7 cells 2.52
Gene expression changes after LOC550643 silencing 2.51
RNAseq of ribosomal fractionation to assess the effect of CBFB on translation regulation 2.5
RNAseq Analysis in glioblastoma cells treated with Mepazine 2.49
Transcriptome landscape of HeLa response upon triamcinolone acetonide 2.43
Transcriptome wide identification of retained introns upon depletion of the splicing factors SNW1 or PRPF8 2.42
Identification of HOXB13 target genes responsive to BET inhibitors 2.42
Transcriptomic analysis of the effect of histone H4 K31R mutation in U2OS cells 2.41
Regulation of mRNA half-life by an inhibitor of human decapping enzyme Dcp2 following transcription shutoff in HEK293T cells 2.39
Identification of the RB loss-induced transcriptome and E2F1 cistrome in prostate cancer 2.39
Identification of the RB loss-induced transcriptome in prostate cancer [RNA] 2.39
HMGA2 Promotes Long-Term Engraftment and Myelo-Erythroid Differentiation of Human Hematopoietic Stem and Progenitor Cells 2.38
Iron response of HepG2 cells 2.35
Oncogenic MYC induces a dependency on the spliceosome in human cancer 2.33
Transcriptomics analysis of gene expression in normal and YTHDC1, SRSF1, SRSF3, SRSF7, SRSF9 or SRSF10 deficient human HeLa cells 2.31
RNA seq with AML (NB4) cells upon FTO inhibition 2.31
mRNA Sequencing of Human PromoCells Using 3'-directed Digital Gene Expression (3'-DGE) Technique 2.3
Integrin signaling regulates YAP/TAZ to control skin homeostasis 2.25
Rnase L reprograms translation by widespread mRNA turnover escaped by antiviral mRNAs 2.25
Analysis of gene expression, motif and pattern of m6A modified region and m6A enrichment level in Ocular melanoma and Melanocyte cell lines. Gene expressin analysis of METTL3 knock down in PIG1, ALKBH5 knock down and HINT2 over expression in OCM1. 2.23
LSD1 mediates MYCN control of epithelial-mesenchymal transition through silencing of metastatic suppressor NDRG1 gene 2.22
MicroRNA-125a-5p overexpression in human macrophages 2.18
The cohesin complex prevents Myc-induced replication stress 2.18
FBP2 inhibits sarcoma progression by restraining mitochondrial biogenesis 2.18
DDX3X regulation of global translation is impaired by medulloblastoma-associated mutations [RNA-Seq] 2.17
DDX3X regulation of global translation is impaired by medulloblastoma-associated mutations 2.17
Comprehensive comparative analysis of 5’ end RNA sequencing methods 2.16
Translating transcriptome of cancer cells in situ in mesenchymal-rich tumor microenvironment 2.16
Distinct gene expression profile of Huh7 cell lines stably overexpressing CRABP1 or 2 2.14
B cells expressing the IgA receptor FcRL4 participate in the autoimmune response in patients with rheumatoid arthritis 2.12
Transcriptomics analysis of gene expression in normal and METTL3 or WTAP deficient Human HeLa cells 2.09
The Developmental Heterogeneity of Human Natural Killer Cells Defined by Single-cell Transcriptome 2.04
Real-time observation of light-controlled transcription in living cells 2.01
RNA-seq of IL-4 stimulated human keratinocytes 1.99
Transcriptome profile of HepG2-expressing ATP7B-H1069Q (liver hepatocellular cells) exposed to JNK or p38 Inhibitor 1.97
Multiplexed engineering and analysis of endogenous enhancer activity in single cells: Mosaic-Seq of beta-globin locus (separate infection) 1.94
Genome-wide discovery of human splicing branchpoints 1.93
RNA polymerase in pre-B-ALL cell lines 1.93
Primate transcript and protein expression levels evolve under compensatory selection pressures 1.93
transcriptome studies of BRD4 inhibitor BDF-1253 on renal clear carcinoma 786-O cells 1.93
Oncogenic changes and EMT in normal human bile duct epithelial cells are caused by parasite-derived materials and N-nitrosodimethylamine 1.91
High-throughput sequencing of the human hepatic progenitor cell niche in PSC and HCV. 1.88
Hyperactive mTOR and MNK1 phosphorylation of eIF4E confer tamoxifen resistance and estrogen independence through selective mRNA translation reprogramming 1.86
Epigenetic silencing of the tumor suppressor RASSF4 favors multiple myeloma progression 1.85
Transcriptome Analysis of CircMRPS35 mediated mRNA expression profiles 1.83
single cell RNA-seq from GM12878 (ENCSR673UIY) 1.82
RNA sequencing of erythroid and granulomonocytic colonies differentiated from transduced bone marrow CD34+ cells expressing U2AF1 S34F mutation, U2AF1 wild-type or empty vector control 1.8
RNA-SEQ assay for wild type and CRISPR induced endoglin knockout human pulmonary artery smooth muscle cells (PASMC) 1.8
Small molecule inhibition of ERK dimerization prevents tumorigenesis by Ras-ERK pathway oncogenes 1.79
BBBomics - Human Blood Brain Barrier Transcriptomics Hub 1.78
BBBomics - Human Blood Brain Barrier Transcriptomics Hub [RNA-seq] 1.78
Widespread Transcription beyond mRNA 3’ Ends Yields Abundant Regulatory RNAs 1.78
DDX54 regulates transcriptome dynamics during DNA damage response [RNA-seq2] 1.75
Effect of digoxin treatment on the gene and alternative splice expression in human pluripotent stem cells- derived mesenchymal stem cells 1.74
CRISPR Display: A modular method for locus-specific targeting of long noncoding RNAs and synthetic RNA devices in vivo [RNA-Seq] 1.72
CRISPR Display: A modular method for locus-specific targeting of long noncoding RNAs and synthetic RNA devices in vivo 1.72
Clonally expanded CD8 T cells patrol Alzheimer's cerebrospinal fluid [TEMRA] 1.72
Clonally expanded CD8 T cells patrol Alzheimer's cerebrospinal fluid 1.72
Macrophage Ad5f35 PhenoMap 1.72
Gene expression profiles in response to proanthocyanidins in pancreatic cancer cells 1.72
MEIS2 is a novel oncogenic partner in AML1-ETO positive AML 1.72
MEIS2 is a novel oncogenic partner in AML1-ETO positive AML [RNA-Seq human] 1.72
RNA-sequencing of healthy human skeletal myocytes 1.71
The histone H3.3K36M mutation reprograms the epigenome of chondroblastomas 1.7
Transcriptional landscape changes during human embryonic stem cell derivation 1.67
Identification of biomarkers for amyotrophic lateral sclerosis by comprehensive analysis of exosomal mRNAs in human cerebrospinal fluid. 1.66
Tracking transcriptional changes in a species-specific manner during experimental hepatoblastoma progression in vivo 1.64
Different Temporal Effects of Ebola Virus VP35 and VP24 Proteins on Global Gene Expression in Human Dendritic Cells 1.61
Interferon-beta-inducible genes in human monocyte-derived macrophages (MDMs) 1.61
Tunable protein synthesis by transcript isoforms in human cells (Transcript Isoforms in Polysomes sequencing: TrIP-seq) 1.58
Paclitaxel plus Cirmtuzumab Achieves Greater Clearance of Patient-derived Xenografts By Targeting ROR1+ Breast Cancer Stem Cells 1.55
Tumor- and cytokine-primed human natural killer cells exhibit distinct phenotypic and transcriptional signatures 1.55
Tumor- and cytokine-primed human natural killer cells exhibit distinct phenotypic and transcriptional signatures [RNA-seq] 1.55
Effect of ILF3 on translation during homeostasis and the antiviral response 1.53
RNA-seq analysis of BORIS/CTCFL knockdown in K562 cell line 1.53
RNA-seq and small RNA-seq analysis of BORIS/CTCFL knockdown in K562 cell line 1.53
CDK4/6 inhibitors target SMARCA4-determined cyclin D1 deficiency in hypercalcemic small cell carcinoma of the ovary (I) 1.52
Molecular Pathology of adverse local tissue reaction caused by metal-on-metal implants 1.49
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells [UNSWCD] 1.49
TGF-b-activated LncRNA LINC00115 is a critical regulator for glioma stem-like cell tumorigenicity 1.48
Measuring the effect of MYC on transcription during the DNA double-strand break response by RNA-seq of newly synthesized transcripts 1.46
Chemotherapeutic drugs inhibiting Topoisomerase 1 activity inhibit TNF-induced inflammatory gene expression 1.45
Interactome (iCLIP) and Translatome ( Polysome profiling) of Musashi 2 (MSI2) targets in K562 1.44
CLIC5: a novel ETV6 target gene in childhood acute lymphoblastic leukemia 1.42
Single-cell analysis of adult human ovary using 10X genomics 1.41
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression [NALM6 RNA-Seq] 1.41
4C-seq of insulin promoter, knockdown of INS promoter activity and Genome-wide maps of chromatin state in EndoC-βH1 Cells 1.4
Viral shRNA Knockdown of INS Promotor Activity in EndoC-βH1 Cells  1.4
EWSR1 influences alternative splicing through direct and indirect mechanisms 1.4
Genome-wide maps of WT and over-expressing CenH3/CENP-A in Human HeLa S3 cells 1.39
Nickel induced transcriptional changes persist post exposure through epigenetic reprograming (RNA-seq dataset) 1.39
Human muscle-derived CLEC14A-positive cells regenerate muscle independent of PAX7 1.39
Transcriptome-wide analysis of the role of HTLV-1 Tax PBM in T-Cells from infected humanized-mice (hu-Mice) 1.38
CREB5 promotes resistance to androgen-receptor antagonists and androgen deprivation in prostate cancer 1.38
Comparison of expression profiles of APP-depleted prostate cancer cells (LNCaP) 1.33
RNA sequence of mRNA in HUVEC cells after depleting EGFL6 1.33
Allergen-specific immunotherapy modulates the balance of circulating Tfh and Tfr cells 1.27
Regulatory network controlling tumor-promoting inflammation in human cancers 1.26
Regulatory network controlling tumor-promoting inflammation in human cancers [RNA-seq] 1.26
ICE1 promotes the link between splicing and nonsense-mediated mRNA decay 1.25
single cell RNA-seq from Purkinje cell (ENCSR888LYA) 1.24
A Suv39H1-low chromatin state drives migratory cell populations in cervical cancer 1.23
A Suv39H1-low chromatin state drives migratory cell populations in cervical cancer [RNA-Seq] 1.23
Effects of Inhibition of CDK8/19 Mediator Kinase by Senexin B in HEK293 cells treated with or without TNF-alpha 1.21
The mRNA export receptor NXF1 coordinates transcriptional dynamics, alternative polyadenylation and mRNA export 1.19
Carcinoma-astrocyte gap junctions promote brain metastasis by cytosolic dsDNA response transfer 1.19
Expression by CD133+ cells isolated from the adult human exocrine pancreas 1.18
RG/RGG boxes are common binding motifs in RNA-G-quadruplex-interacting proteins 1.17
Single Cell RNA-sequencing of cell types isolated by FACS from normal human prostates 1.15
A Surveillance System of Active Enhancers by a RACK7-histone Demethylase Complex (RNA-Seq I) 1.14
Human cell line and subcutaneous tumor 1.13
The RNA helicase DDX39B regulates IL7R alternative splicing reducing the risk of Multiple Sclerosis 1.09
Transcriptome of melanoma cell lines resistant to inhibition of the MAPK pathway. 1.09
Transcriptome profiling of HepG2 cells upon treatment of the menin-MLL inhibitor MI-503 or DMSO 1.07
RNA-seq of HDAC2-disrupted 293FT cells by CRISPR-Cas9 1.06
Human Treg NaCl stimulation 1.03
Ewing sarcoma resistance to SP-2509 is not mediated through KDM1A/LSD1 mutation II 1.03
Dissecting cell composition and cell-cell interaction network of human disease heart tissue by single-cell sequencing 1.02
Genome-wide mapping of TEL-AML1 targets in acute leukemia 1.01
Transcriptome of EBV-infected gastric cancer cell lines 1.01
Does osteogenic potential of clonal human bone marrow mesenchymal stem/stromal cells correlate with their vascular supportive ability? 1.0
Arginine methylation controls cell proliferation by integrating E2F activity with the splicing machinery (RNA-seq data set) 0.98
Arginine methylation controls cell proliferation by integrating E2F activity with the splicing machinery 0.98
DNMT1-associated long non-coding RNA regulate global gene expression and DNA methylation in colon cancer 0.96
Co-regulation of splicing by Rbfox1 and hnRNP M [hnRNPM k-d+Rbfox1 RNA-Seq] 0.95
Co-regulation of splicing by Rbfox1 and hnRNP M 0.95
Single Cell RNASeq profiling of stromal vascular fraction from Subcutaneous and visceral adipose tissue 0.93
Single-cell analysis of human kidney organoids 0.92
TALEN-based knockout of mir-141 and mir-200c in SK-BR-3 cells 0.92
The bromodomain protein BRD4 regulates splicing during heat shock 0.91
RNA-seq analysis of PRMT5-regulated genes in irradiated/non-irradiated LNCaP cells 0.87
An electrical pulse stimulation protocol to study acute epigenetic response to muscle cell contraction uncovers acute hydroxymethylation of the exercise-responsive gene Nr4a3 0.87
An electrical pulse stimulation protocol to study acute epigenetic response to muscle cell contraction uncovers acute hydroxymethylation of the exercise-responsive gene Nr4a3 [RNA-Seq] 0.87
Modulation of gene transcription and epigenetics of colon carcinoma cells by bacterial membrane vesicles 0.85
Microvesicle-mediated delivery of miR-1343: impact on markers of fibrosis 0.85
DRB/GRO-Seq -/+ UV 0.85
Chronic cadmium exposure decreases the dependency of MCF7 breast cancer cells on ERα 0.84
Effect of PDZ domain binding Kinase inhibition using TOPK-32 (called PBKi) on C4-2 cell transcriptome 0.81
Evaluation of the effectiveness of semen collection and sperm purification methods for spermatozoa transcript profiling 0.78
Inheritable Silencing of Endogenous Genes by Hit-and-Run Targeted Epigenetic Editing 0.78
RNA-seq of HEK293T cells overexpressing TET1-FL or TET1-ALT 0.78
Polysome profiling RNAseq of cells transfected with an oligonucleotide targeting the ES6S region of the 40S subunit 0.77
Integrated single cell analysis of blood and cerebrospinal fluid leukocytes in multiple sclerosis 0.76
SNHG15 is a bifunctional MYC-regulated noncoding locus encoding a lncRNA that promotes cell proliferation, invasion and drug resistance in colorectal cancer by interacting with AIF 0.75
Next Generation Sequencing Facilitates Quantitative Analysis of Wild Type and SMAD4 Y95 Mutation Transcriptomes 0.75
Copper Regulation of HIF-1 Transcription Activity 0.74
Copper Regulation of HIF-1 Transcription Activity [RNA-seq] 0.74
RNA G-quadruplexes mark repressive upstream open reading frames in human mRNAs 0.72
Interactions of aCPs with Cytosine-rich Polypyrimidine Tracts Enhance Splicing of Cassette Exons 0.71
m6A-dependent regulation of messenger RNA stability 0.68
Myc activation coordinates gene transcription and protein translation responses 0.66
An intramolecular salt bridge linking TDP43’s RNA recognition motifs dictates RNA binding, protein stability and TDP43-dependent neurodegeneration 0.66
Interleukin-1β induces mitochondrial DAMP production to activate STING-dependent innate immune programs 0.64
IMP3 regulated gene expression in breast cancer cells 0.63
Transciptome profiling of NoDice and RNaseIII null cells prior to and after polyIC treatment 0.58
Transcriptome-wide analysis links the short-term expression of the b isoforms of T-cell intracellular antigens to protective proteostasis-mediated survival and quiescence 0.57
Maternal-biased H3K27me3 correlates with paternal-specific gene expression in the human morula 0.56
RNAseq of CD8+ and CD8- MAIT cells in human peripheral blood 0.55
rG4-seq reveals widespread formation of G-quadruplex structures in the human transcriptome 0.55
Dissecting the single-cell transcriptome network underlying gastric premalignant lesions and early gastric cancer [10x genomics] 0.55
Expression analysis of PC3 cells treated with scramble AON or AON directed against MBNL1 0.53
BACH2 in human plasma cell fate decision 0.53
CAR T cell trogocytosis and cooperative killing regulate tumour antigen escape 0.53
Muscle transcriptome analysis following Total Knee Arthroplasty with Tourniquet 0.53
Dynamic gene expression in T-ALL following treatment and release of gamma-secretase inhibition [GRO-Seq] 0.51
Epigenome Editing by CRISPR/Cas9 Repressors for Silencing of Distal Regulatory Elements 0.49
RNA-Seq gene profiling comparison from human cDC subsets and pre-cDC subsets 0.49
Evaluating and comparing the Transcriptome of (human) Hek 293 based cells, expressing either CHD3 or CHD4 0.48
Metabolism as an early predictor of DPSCs aging 0.48
NOTCH signaling is activated in and contributes to resistance in enzalutamide-resistant prostate cancer cells 0.46
In situ CAPTURE of chromatin interactions by biotinylated dCas9 0.45
RNA-seq transcriptonal profiling in human K562 cells with or without dCas9 and sgRNAs 0.45
Novel SF3B1 Deletion Mutations Result in Aberrant RNA Splicing in CLL Patients 0.44
YTHDF1 Amplifies Wnt/β-Catenin Signaling to Promote Intestinal Stemness 0.43
Low H3K27me3 and DNA hypomethylation define poorly prognostic pediatric posterior fossa ependymomas 0.42
Comparative Transcriptomic Analysis of Hematopoietic System Across Species by Microwell-Seq 0.41
Genome-wide DNA hypomethylation and RNA:DNA hybrid accumulation in Aicardi-Goutières syndrome 0.4
Identification of miRNA-mRNA regulatory network for Human Atrial Aging 0.39
Identification of miRNA-mRNA regulatory network for Human Atrial Aging [mRNA] 0.39
RNA-seq data 0.38
Transcriptomic analysis of senescent cells upon PTBP1 knockdown. 0.37
Genome-wide mapping of DROSHA cleavage sites on primary microRNAs and novel substrates [RNA-seq] 0.35
Genome-wide mapping of DROSHA cleavage sites on primary microRNAs and novel substrates 0.35
Gene expression changes due to PARP knockdown in human cells 0.34
Genes significantly down or Up-regulated upon RNF219 knockdown. [RNA-Seq] 0.33
Transcriptome-wide modulation of splicing by the exon junction complex 0.32
RNA Expression Profile of Calcified Bicuspid, Tricuspid and Normal Human Aortic Valves by RNA Sequencing [BAV] 0.31
Antioxidant metabolism in activated CD8+ T cells regulates stem-like human memory T cell formation and anti-tumor immunity 0.3
High-throughput single cell transcriptome analysis and CRISPR screen identify key β cell-specific disease genes 0.29
Gene expression profile in endometrial organoids cultured in normal follicular phase vs PCOS-like hormone profile 0.28
Identification and mitigation of pervasive off-target activity in CRISPR-Cas9 screens for essential non-coding elements 0.27
Functional genomic analysis of the haploinsufficient tumor suppressor, CUX1 0.27
Single-cell Transcriptomic Atlas of the Human Retina Identifies Cell Types Associated with Age-Related Macular Degeneration [Microfluidics] 0.27
p53 activity results in DNA replication fork processivity 0.26
CRISPR activation of long non-coding RNAs transiently expressed during cortical neuron differentiation associated with Field, et al, Stem Cell Reports 2018 0.25
RNA sequencing from FOXM1 knockout HEK293T cells reconstituted with FOXM1 isoforms a, b and c. 0.24
RNA-Seq and expression data from human adipose tissue 0.22
Tissue-specific RNA-seq in human evoked inflammation identifies novel blood and adipose lincRNA signatures of cardio-metabolic diseases 0.22
Transcriptome-wide response to synthetic chromatin protein PcTF 0.19
Bacterial Infection Remodels the DNA Methylation Landscape of Human Dendritic Cells (mRNA-Seq) 0.19
Genome-wide analysis of the Integrator complex 0.18
Genome-wide analysis of the Integrator complex (HTS) 0.18
Transcription factors and stress response gene alterations in human keratinocytes following Solar Simulated Ultra Violet Radiation 0.16
Transcriptome-wide off-target RNA editing induced by CRISPR-guided DNA base editors [Modifications - screen] 0.15
Induction of human hemogenesis in adult fibroblasts by defined factors and hematopoietic co-culture 0.15
Transcriptome sequencing after MAGOHB knockdown in MAGOH-deleted or non-deleted cancer cells 0.14
Tracing the first hematopoietic stem cell generation in human embryo by single-cell RNA sequencing 0.14
Molecular characterization of BRSK2 and BRSK1 kinases as negative regulators of the NRF2 transcription factor 0.14
Characterizing smoking-induced transcriptional heterogeneity in the human bronchial epithelium at single-cell resolution 0.12
The circadian transcriptional landscape in primary human mammary epithelial cells 0.12
Chromatin mapping and single-cell immune profiling defines the temporal dynamics of ibrutinib drug response in chronic lymphocytic leukemia 0.1
Chromatin mapping and single-cell immune profiling defines the temporal dynamics of ibrutinib drug response in chronic lymphocytic leukemia [scRNA-seq] 0.1
Engineered Nanointerfaces for Microfluidic Isolation and Molecular Profiling of Tumor-specific Extracellular Vesicles 0.09
Club cells surviving influenza A virus infection induce temporary non-specific anti-viral immunity 0.08
Apoptosis enhancing drugs overcome innate platinum resistance in CA125 negative tumor initiating populations of high grade serous ovarian cancer 0.05
Remodeling of Ago2-mRNA interactions upon cellular stress reflects miRNA complementarity and correlates with altered translation rates (part 4) 0.04
Remodeling of Ago2-mRNA interactions upon cellular stress reflects miRNA complementarity and correlates with altered translation rates 0.04
CRISPR-Cas9 based screen for p53-bound enhancers that function in oncogene-induced senescence 0.04
Zika Virus Has Oncolytic Activity against Glioblastoma Stem Cells 0.04
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression [SLAM-Seq] 0.03
Identification of a unique gene expression signature in mercury and 2,3,7,8-tetrachlorodibenzo-p-dioxin co-exposed cells 0.01
Transcriptome-wide profiling of poly(A)-tail length, translation efficiency and mRNA stability using TED-seq, mRNA-seq, Ribo-seq and PRO-seq in ER stress conditions 0.01
Function and hormonal regulation of GATA3 in human first trimester placentation 0.0


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation